Frontlight ResearchEarly access
Ovarian cancer trials in United States
348 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peoplePhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- Where
- Houston
- Age
- 18 years and over
- People
- 43
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05092373 - No phaseTaking peopleThe Better, Harder, Faster, Stronger Study
- Where
- Winston-Salem
- Age
- 55 years and over
- People
- 35
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT07220512 - No phaseTaking peopleIdentifying and Caring for Individuals With Inherited Cancer Syndrome
- Where
- Portland
- Age
- 18 years and over
- People
- 27,500
- Run by
- OHSU Knight Cancer Institute
See details and how to joinNCT04494945 - Phase 2Taking peopleStudy of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- Where
- Birmingham, Columbus, Minneapolis, Oklahoma City, Oxford, Pittsburgh, Richmond, Rochester, San Francisco
- Age
- 18 years and over
- People
- 70
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT04606914 - Phase 3Taking peopleGleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
- Where
- Annapolis, Baltimore, Charleston, Cleveland, Jacksonville, Morgantown, Newport News, New York, Phoenix, Rochester, York
- Age
- 18 years and over
- People
- 170
- Run by
- NX Development Corp
See details and how to joinNCT05804370 - Phase 2Taking peopleRepurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
- Where
- Orange
- Age
- 18 years and over
- People
- 75
- Run by
- University of California, Irvine
See details and how to joinNCT06580002 - Phase 1/2Taking peopleAtezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
- Where
- Gainesville
- Age
- 18 years to 99 years
- People
- 29
- Run by
- University of Florida
See details and how to joinNCT05000294 - Phase 2Taking peopleAn Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
- Where
- Aurora, Chicago, Irvine, Madison, Philadelphia, Pittsburgh
- Age
- 18 years to 100 years
- People
- 53
- Run by
- University of Colorado, Denver
See details and how to joinNCT05887609 - Phase 1/2Taking peopleCATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
- Where
- Durham, Fullerton, Irvine, Los Angeles, New York, Rochester
- Age
- 18 years to 75 years
- People
- 60
- Run by
- TORL Biotherapeutics, LLC
See details and how to joinNCT07322094 - No phaseEnrolling by invitationPatient Centered Clinical Decision Support for Hereditary Cancer Syndromes
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 2,488
- Run by
- HealthPartners Institute
See details and how to joinNCT06914726 - Phase 1Taking peopleCPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 30
- Run by
- Lan Coffman
See details and how to joinNCT05942300 - No phaseTaking peopleUNTOLD Ovarian Cancer Unmet Needs Survey
- Where
- Minneapolis
- Age
- 18 years and over
- People
- 2,000
- Run by
- Masonic Cancer Center, University of Minnesota
See details and how to joinNCT07070726 - Phase 1/2Taking peopleFirst-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- Where
- Atlanta, Aurora, Boston, Cleveland, Columbus, Dallas, Detroit, Fairfax, Germantown, Grand Rapids, Houston, Iowa City, Kansas City, Lake Mary, Los Angeles, Nashville, New Haven, New Orleans, New York, Portland, San Antonio, San Francisco, St Louis, Tampa, West Valley City
- Age
- 18 years and over
- People
- 880 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05768139 · EU 2023-504807-94-00 - Phase 1Taking peopleA Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Where
- Anaheim, Anchorage, Babylon, Bonney Lake, Boston, Brooklyn, Calumet City, Chicago, Cleveland, Coon Rapids, Crown Point, Edmonds, Fairfax, Fairway, Fayetteville, Federal Way, Flossmoor, Fort Myers, Fort Wayne, Fullerton, Gig Harbor, Harvey, Hollywood, Houston, Indianapolis, Irving, Kansas City, Las Vegas, Los Alamitos, Los Angeles, Minneapolis, Nashville, New Hyde Park, New Lenox, Newton, New York, Oklahoma City, Olympia, Orlando, Orland Park, Overland Park, Patchogue, Pearland, Pembroke Pines, Port Jefferson Station, Portland, Puyallup, Riverhead, Rogers, Saint Paul, San Antonio, Santa Monica, Seattle, Shirley, Sioux Falls, Springdale, Springfield, Tacoma, The Bronx, Tinley Park, Torrance, Tyler, Webster, Westwood
- Age
- 18 years and over
- People
- 1,006 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT04389632 · EU 2023-508469-34-00 - Phase 1Taking peopleA First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
- Where
- Boston, Detroit, Fairfax, New Haven, Rochester, Sarasota, Springdale
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Stemline Therapeutics, Inc.
See details and how to joinNCT07226427 · EU 2025-524168-39-00 - No phaseTaking peopleNavigation Intervention for Adolescent and Young Adult Cancer Survivors
- Where
- Pasadena
- Age
- 21 years to 45 years
- People
- 25
- Run by
- Kaiser Permanente
See details and how to joinNCT07406087 - No phaseTaking peopleA Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
- Age
- 18 years and over
- People
- 35
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT05429970 - Phase 2Taking peopleA Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer
- Where
- El Segundo, Newport Beach
- Age
- 18 years to 85 years
- People
- 20
- Run by
- ImmunityBio, Inc.
See details and how to joinNCT06710288 - No phaseTaking peopleEXoPERT EMERALD Clinical Study
- Where
- Albany, Baltimore, Honolulu, Lexington, Long Beach, Los Angeles, Louisville, The Bronx, Wappingers Falls
- Age
- 45 years and over
- People
- 1,400
- Run by
- EXoPERT
See details and how to joinNCT07186296 - No phaseTaking peopleClonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Where
- Boston
- Age
- 18 years and over
- People
- 5,000
- Run by
- Dana-Farber Cancer Institute
See details and how to joinNCT07675967 - No phaseTaking peopleIntegrated Cancer Repository for Cancer Research
- Where
- Aitkin, Alliance, Aurora, Bozeman, Brainerd, Canton, Council Bluffs, Daytona Beach, DeLand, Duluth, Fargo, Fayetteville, Fergus Falls, Fort Wayne, Glens Falls, Green Bay, Greenwood Village, Hastings, Holyoke, Kansas City, Liberty, Manchester, Minot, Norfolk, North Kansas City, North Platte, Omaha, Orange City, Overland Park, Palm Coast, Randallstown, Saint Joseph, Tallahassee, Utica, Waterloo, Westminster, Yorkville
- Age
- 19 years to 110 years
- People
- 999,999
- Run by
- University of Nebraska
See details and how to joinNCT02012699 - Phase 1/2Taking peopleA Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Where
- Atlanta, Boston, Chicago, Dallas, Detroit, Fairfax, Houston, Jacksonville, Las Vegas, Nashville, New York, Oklahoma City, Orange, Phoenix, Rochester, Salt Lake City, San Francisco, Santa Monica, Sarasota, Seattle, Sioux Falls, Spokane, Tampa
- Age
- 18 years and over
- People
- 360
- Run by
- Day One Biopharmaceuticals, Inc.
See details and how to joinNCT05377996 - Phase 2Taking peopleNewly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
- Where
- Birmingham
- Age
- 18 years and over
- People
- 20
- Run by
- University of Alabama at Birmingham
See details and how to joinNCT05952453 - Phase 2Taking peopleA Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- Where
- Atlanta, Boston, Charlotte, Cleveland, Encinitas, Grand Rapids, Harvey, Jacksonville, Lake Success, Los Angeles, Morristown, Tucson, Whittier
- Age
- 18 years and over
- People
- 37 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT04641247 · EU 2023-506618-29-00 - Phase 1Taking peopleSynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
- Where
- Houston, Madison, Philadelphia, Tampa, Westwood
- Age
- 18 years and over
- People
- 42
- Run by
- Verismo Therapeutics
See details and how to joinNCT05568680